Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Choline Fenofibrate Patent Expiration

Choline Fenofibrate was first introduced by Abbvie Inc in its drug Trilipix on Dec 15, 2008. 13 different companies have introduced drugs containing Choline Fenofibrate.


Choline Fenofibrate Patents

Given below is the list of patents protecting Choline Fenofibrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Trilipix US7259186 Salts of fenofibric acid and pharmaceutical formulations thereof Jan 07, 2025 Abbvie


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Choline Fenofibrate's patents.

Given below is the list recent legal activities going on the following patents of Choline Fenofibrate.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 16 Jan, 2019 US7259186
Recordation of Patent Grant Mailed 21 Aug, 2007 US7259186
Patent Issue Date Used in PTA Calculation 21 Aug, 2007 US7259186
Issue Notification Mailed 01 Aug, 2007 US7259186
Application Is Considered Ready for Issue 21 Jun, 2007 US7259186
Dispatch to FDC 21 Jun, 2007 US7259186
Issue Fee Payment Verified 19 Jun, 2007 US7259186
Issue Fee Payment Received 19 Jun, 2007 US7259186
Electronic Review 13 Jun, 2007 US7259186
Email Notification 12 Jun, 2007 US7259186



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Choline Fenofibrate Generics

Several generic applications have been filed for Choline Fenofibrate. The first generic version for Choline Fenofibrate was by Mylan Pharmaceuticals Inc and was approved on Mar 25, 2013. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Feb 8, 2024.

Given below is the list of companies who have filed for Choline Fenofibrate generic.


1. GRAVITI PHARMS

Graviti Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Graviti Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Jul 18, 2019
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Jul 18, 2019


2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Oct 7, 2015
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Oct 7, 2015


3. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG FENOFIBRIC ACID capsule, delayed release Discontinued ORAL N/A Mar 25, 2013
EQ 135MG FENOFIBRIC ACID capsule, delayed release Discontinued ORAL N/A Mar 25, 2013


4. YICHANG HUMANWELL

Yichang Humanwell Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Yichang Humanwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Dec 23, 2020
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Dec 23, 2020


5. TWI PHARMS

Twi Pharmaceuticals Inc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Twi Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Jul 5, 2019
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Jul 5, 2019


6. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Dec 4, 2013
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Dec 4, 2013


7. MICRO LABS

Micro Labs Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Jun 16, 2020
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Jun 16, 2020


8. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Jul 25, 2019
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Jul 25, 2019


9. IMPAX LABS INC

Impax Laboratories Inc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Sep 7, 2016
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Sep 7, 2016


10. ENDO OPERATIONS

Endo Operations Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG FENOFIBRIC ACID capsule, delayed release Discontinued ORAL N/A Jul 18, 2013
EQ 45MG FENOFIBRIC ACID capsule, delayed release Discontinued ORAL N/A Jul 18, 2013


11. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Feb 8, 2024
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB Feb 8, 2024


12. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB May 12, 2017
EQ 45MG FENOFIBRIC ACID capsule, delayed release Prescription ORAL AB May 12, 2017